The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 in Children With Henoch-schönlein Purpura
NCT04387942
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Purpura, Schoenlein-Henoch
Interventions
DRUG:
IL-2
Sponsor
The First Hospital of Jilin University